2 different filers disclosed AMGN within 90 days. Disclosed 10 days after the transaction; reported as an official range, not an exact amount.
Traded Aug 13, 2026 · Filed Aug 13, 2026
Amgen's SVP, Business Development sold $521K of Amgen shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$521,365
Shares × reported transaction price
9 days after results of Aug 4, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $417.84 on Aug 13, 2026, at its 52-week high, after a 16% rise over the previous 30 trading days
52-week range $271.18 (Sep 25, 2025) to $417.84 (Aug 13, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $361.33 on Jul 1, 2026. Describes the past only, not a forecast
Footnote references dividend reinvestment
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.8% | -1.4% | +7.2% |
| 30 days | -8.1% | -2.0% | -6.1% |
Past results only. Not a forecast.
2 different filers disclosed AMGN within 90 days. Disclosed 10 days after the transaction; reported as an official range, not an exact amount.
2 different filers disclosed AMGN within 90 days. Disclosed 10 days after the transaction; reported as an official range, not an exact amount.
2 different filers disclosed AMGN within 90 days. Disclosed 21 days after the transaction; reported as an official range, not an exact amount.